文献速递神经肿瘤

非典型脑膜瘤:本机构161例手术与手术加放疗的无进展生存分析

Atypical meningioma: progression-free survival in 161 cases treated at our institution with surgery versus surgery and radiotherapy.
PubMed 文献 · J Neurooncol · 2017-10-28

本研究回顾性分析2001年2月至2015年3月本机构161例非典型脑膜瘤切除术,其中128例仅手术、33例手术加放疗。Simpson I–II级切除显著影响复发风险(HR=1.8,95%CI 1.3–2.6,P=0.0004);术后辅助放疗对无进展生存无显著获益(HR=1.48,95%CI 0.76–2.86,P=0.22);肿瘤位于前颅窝和后颅窝者无进展生存显著更长(P=0.03)。

要点

  • Simpson I–II级切除显著降低复发风险(HR=1.8,95%CI 1.3–2.6,P=0.0004)。
  • 术后辅助放疗对复发/进展率或无进展生存无显著影响(HR=1.48,95%CI 0.76–2.86,P=0.22)。
  • 肿瘤位于前颅窝或后颅窝是改善无进展生存的独立因素(P=0.03)。

核心结论

  • 术后辅助放疗对非典型脑膜瘤的复发/进展率或无进展生存无显著影响。
  • 按Simpson分级评估的切除程度仍是与非典型脑膜瘤较低复发/进展率和较长无进展生存相关的最重要预后因素。
  • 肿瘤位于前颅窝或后颅窝是与改善无进展生存相关的独立因素。

研究设计与样本

  • 回顾性分析2001年2月至2015年3月本机构神经外科161例非典型脑膜瘤切除术,其中128例仅手术治疗、33例手术加放疗。
  • 采用Kaplan-Meier分析提供中位点估计和无进展生存率,采用Cox回归模型进行单变量和多变量分析以识别与治疗相关的显著因素。

主要发现

  • 切除程度(Simpson I–II级)显著影响复发风险(HR=1.8,95%CI 1.3–2.6,P=0.0004)。
  • 术后辅助放疗对无进展生存无显著获益(HR=1.48,95%CI 0.76–2.86,P=0.22)。
  • 肿瘤位于前颅窝和后颅窝者与其他部位相比无进展生存显著更长(P=0.03)。

关键数值与推荐

  • 切除程度(Simpson I–II级)影响复发风险:HR=1.8,95%CI 1.3–2.6,P=0.0004。
  • 术后辅助放疗对无进展生存:HR=1.48,95%CI 0.76–2.86,P=0.22。
  • 肿瘤位于前颅窝和后颅窝者与其他部位相比无进展生存:P=0.03。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Although atypical meningioma recurs frequently in spite of total resection and/or radiotherapy, no consensus on optimal adjuvant management was found. However, several retrospective studies analysed the additional effect of adjuvant radiotherapy in atypical meningioma with inconsistent results. Therefrom, the purpose of this study was to evaluate prognostic factors influencing the recurrence/progression and progression-free survival (PFS) rates of atypical meningioma, particularly focused on the role of postoperative adjuvant radiotherapy. Between February 2001 and March 2015, 161 atypical meningioma resections were performed in our Department of Neurosurgery, of which, 128 cases underwent surgical treatment alone and 33 cases underwent surgery and radiotherapy. Kaplan-Meier analysis was used to provide median point estimates and PFS rates. The Cox-regression model was used in the univariate and multivariate analysis to identify significant factors associated with treatment. The extent of resection (Simpson grade I and II) significantly influenced the risk of recurrence (hazard ratio = 1.8, CI (95%) 1.3-2.6, p-value = 0.0004). There was no significant benefit for progression-free survival after adjuvant radiotherapy (hazard ratio = 1.48, CI (95%) 0.76-2.86, p-value = 0.22). Additionally, meningioma located at the anterior and posterior fossa showed a significantly longer PFS compared to other locations (p-value = 0.03). Adjuvant postoperative radiotherapy had no significant impact on recurrence/progression rate or PFS. The extent of resection according to Simpson grade remains the most important prognostic factor associated with lower recurrence/progression rates and longer PFS in patients with atypical meningioma. The location of the tumours at the anterior or posterior fossa was an independent factor associated with improved PFS.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Masalha W, Heiland DH, Franco P, et al. Atypical meningioma: progression-free survival in 161 cases treated at our institution with surgery versus surgery and radiotherapy. J Neurooncol. 2017. PMID: 29081038. doi:10.1007/s11060-017-2634-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。